ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Colorado » Internal Medicine

Top Internal Medicine Prescribers in Colorado

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
STANTON ELZI MD

Internal Medicine

9,361

$671K

922
833 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

7%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$72
Average prescription price

Avg: $56

MARK HOSKINSON

Internal Medicine

9,225

$395K

780
729 are 65+

10%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$43
Average prescription price

Avg: $56

BRIAN O'SULLIVAN

Internal Medicine

9,209

$413K

764
697 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

10%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$45
Average prescription price

Avg: $56

KIN CHAN MD

Internal Medicine

9,208

$313K

860
795 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$34
Average prescription price

Avg: $56

JOSEPH MASLAK M.D.

Internal Medicine

9,177

$395K

314
269 are 65+

4%
patients receiving schedule two controlled substances

Avg: 8%

16%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$43
Average prescription price

Avg: $56

DANIEL MCANINCH MD

Internal Medicine

9,152

$398K

663
598 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

11%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$44
Average prescription price

Avg: $56

CELINDE STROHL MD

Internal Medicine

8,968

$648K

483
430 are 65+

4%
patients receiving schedule two controlled substances

Avg: 8%

6%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 24%

$72
Average prescription price

Avg: $56

H PICKETT MD

Internal Medicine

8,965

$463K

329
255 are 65+

16%
patients receiving schedule two controlled substances

Avg: 8%

16%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $56

THOMAS HENDERSON MD

Internal Medicine

8,837

$651K

479
372 are 65+

16%
patients receiving schedule two controlled substances

Avg: 8%

22%
patients receiving schedule three controlled substances

Avg: 9%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$74
Average prescription price

Avg: $56

THOMAS JENKINS MD

Internal Medicine

8,819

$550K

558
501 are 65+

8%
patients receiving schedule two controlled substances

Avg: 8%

14%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $56

PRATHEEP ARORA M.D.

Internal Medicine

8,795

$806K

594
385 are 65+

10%
patients receiving schedule two controlled substances

Avg: 8%

14%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 24%

$92
Average prescription price

Avg: $56

SRIDHAR REDDY MD

Internal Medicine

8,752

$712K

411
282 are 65+

20%
patients receiving schedule two controlled substances

Avg: 8%

11%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 24%

$81
Average prescription price

Avg: $56

JAMES RICH MD

Internal Medicine

8,703

$374K

452
411 are 65+

13%
patients receiving schedule two controlled substances

Avg: 8%

14%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$43
Average prescription price

Avg: $56

ROBERT TELLO M.D.

Internal Medicine

8,683

$412K

466
431 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

8%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $56

REGINA HEALY M.D.

Internal Medicine

8,641

$347K

708
646 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$40
Average prescription price

Avg: $56

JAE LEE DO LLC

Internal Medicine

8,616

$718K

457
378 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

17%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$83
Average prescription price

Avg: $56

DOUGLAS DUFFEE M.D.

Internal Medicine

8,486

$459K

399
365 are 65+

6%
patients receiving schedule two controlled substances

Avg: 8%

11%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $56

THOMAS GAIDE MD

Internal Medicine

8,426

$491K

380
351 are 65+

8%
patients receiving schedule two controlled substances

Avg: 8%

17%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $56

JUVENTINO SAAVEDRA MD

Internal Medicine

8,422

$314K

610
542 are 65+

16%
patients receiving schedule two controlled substances

Avg: 8%

11%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$37
Average prescription price

Avg: $56

DENNIS GENEREUX MD

Internal Medicine

8,329

$367K

651
596 are 65+

8%
patients receiving schedule two controlled substances

Avg: 8%

11%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$44
Average prescription price

Avg: $56

TERRI RICHARDSON

Internal Medicine

8,305

$307K

641
563 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

14%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$37
Average prescription price

Avg: $56

JEANNE ROZWADOWSKI MD

Internal Medicine

8,214

$376K

334
176 are 65+

19%
patients receiving schedule two controlled substances

Avg: 8%

23%
patients receiving schedule three controlled substances

Avg: 9%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $56

JON STUEBNER MD

Internal Medicine

8,154

$434K

531
496 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

13%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $56

MELCHOR SIPALAY MD

Internal Medicine

8,146

$431K

392
348 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

16%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $56

DANA CHRISTIANSEN MD

Internal Medicine

8,137

$425K

573
453 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank